BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21567652)

  • 1. Coronary heart disease outcomes among chronic opioid and cyclooxygenase-2 users compared with a general population cohort.
    Carman WJ; Su S; Cook SF; Wurzelmann JI; McAfee A
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):754-62. PubMed ID: 21567652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: a retrospective cohort study using a US health insurance database.
    Ziyadeh N; McAfee AT; Koro C; Landon J; Arnold Chan K
    Clin Ther; 2009 Nov; 31(11):2665-77. PubMed ID: 20110009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
    Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease.
    Ray WA; Varas-Lorenzo C; Chung CP; Castellsague J; Murray KT; Stein CM; Daugherty JR; Arbogast PG; García-Rodríguez LA
    Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):155-63. PubMed ID: 20031832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary heart disease outcomes in patients receiving antidiabetic agents.
    McAfee AT; Koro C; Landon J; Ziyadeh N; Walker AM
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):711-25. PubMed ID: 17551989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
    Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
    Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
    Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
    Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary heart disease outcomes in patients receiving antidiabetic agents in the PharMetrics database 2000-2007.
    Walker AM; Koro CE; Landon J
    Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):760-8. PubMed ID: 18383443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications.
    Velentgas P; West W; Cannuscio CC; Watson DJ; Walker AM
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):641-52. PubMed ID: 16392153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
    García Rodríguez LA; Varas-Lorenzo C; Maguire A; González-Pérez A
    Circulation; 2004 Jun; 109(24):3000-6. PubMed ID: 15197149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A 20-year prospective study on risk factors for myocardial infarction of 5,137 men in Capital Steel and Iron Company].
    Yue H; Gu DF; Wu XG; Yu XH; Duan XF; Wang JH; Zheng RP; Zhou J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Jan; 38(1):43-6. PubMed ID: 14989905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
    Huang WF; Hsiao FY; Wen YW; Tsai YW
    Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic use and myocardial infarction in older patients with treated dementia.
    Pariente A; Fourrier-Réglat A; Ducruet T; Farrington P; Béland SG; Dartigues JF; Moore N; Moride Y
    Arch Intern Med; 2012 Apr; 172(8):648-53; discussion 654-5. PubMed ID: 22450214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients.
    Trivedi H; Xiang Q; Klein JP
    Nephrol Dial Transplant; 2009 Jan; 24(1):258-66. PubMed ID: 18682489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study.
    Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
    Garg P; Normand SL; Silbaugh TS; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Mauri L
    Circulation; 2008 Nov; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
    Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
    Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.
    McGovern PG; Pankow JS; Shahar E; Doliszny KM; Folsom AR; Blackburn H; Luepker RV
    N Engl J Med; 1996 Apr; 334(14):884-90. PubMed ID: 8596571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
    Heintjes EM; Penning-van Beest FJ; Johansson S; Stalenhoef AF; Herings RM
    Curr Med Res Opin; 2009 Nov; 25(11):2621-9. PubMed ID: 19743959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.